XML 78 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8
Net Income per Share
 9 Months Ended
Sep. 30, 2013
Earnings Per Share [Abstract]  
Net (Loss) Income per Share
Net Income (Loss) per Share
The following is a reconciliation of net income (loss) and weighted-average common shares outstanding for purposes of calculating diluted net loss per share for the three and nine months ended September 30, 2013 and 2012:
(in millions, except per share amounts)
 
Three Months Ended September 30,
 
Nine Months Ended September 30,
 
 
2013
 
2012
 
2013
 
2012
Net income (loss)
 
$
13.8

 
$
(48.2
)
 
$
(4.5
)
 
$
(61.9
)
Basic weighted-average number of shares outstanding
 
171.5

 
168.7

 
170.9

 
168.3

Effect of dilutive securities
 
 
 
 
 
 
 
 
Share-based awards
 
0.1

 
—

 
—

 
—

Prepaid common stock purchase contracts
 
44.9

 
—

 
—

 
—

Diluted weighted-average number of shares outstanding
 
216.5

 
168.7

 
170.9

 
168.3

Net income (loss) per share
 
 
 
 
 
 
 
 
Basic
 
$
0.08

 
$
(0.29
)
 
$
(0.03
)
 
$
(0.37
)
Diluted
 
$
0.06

 
$
(0.29
)
 
$
(0.03
)
 
$
(0.37
)

For the three months ended September 30, 2013, approximately 1.5 million PSUs were excluded from the computation of diluted weighted-average shares as the award prices exceeded the price of TCM's common stock as of September 30, 2013. For the three months ended September 30, 2013, approximately 1.9 million stock options and 1.2 million RSUs were excluded from the computation of diluted weighted-average shares as the effect would have been anti-dilutive under the treasury stock method.
For the nine months ended September 30, 2013, TCM was in a net loss position, and approximately 1.5 million PSUs, 2.0 million stock options, 1.2 million RSUs and 44.9 million shares for the settlement of the tMEDS purchase contracts were excluded from the computation of diluted weighted-average shares.
For the three and nine months ended September 30, 2012, approximately 2.5 million stock options and 0.9 million PSUs were excluded from the computation of diluted weighted-average shares as the exercise prices exceeded the average price of TCM's common stock for the period.